• Guanren Zhao, Xiaobo Luo, Xue Han, and Zhen Liu.
• Eighth Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China. E-mail. guanrenzhao309@163.com.
• Saudi Med J. 2020 Apr 1; 41 (4): 351360351-360.

ObjectivesTo identify the novel and promising indicators for pulmonary tuberculosis (PTB) patients.MethodsThe study was carried out between June 2016 and June 2019. Three RNA sequencing or microarray datasets of TB infection were used to identify the potential genes showing a common expression trend. The expression level of screened targets was determined by reverse transcription polymerase chain reaction and ELISA using samples of whole blood and peripheral blood mononuclear cells (PBMCs) isolated from 69 PTB patients and 69 healthy volunteers. The potential of the identified targets to predict the treatment outcomes was further studied.ResultsBioinformatics analysis demonstrated that a total of 91 genes were up-regulated in all the 3 datasets; among them, the expression of SLAMF8, LILRB4, and IL-10Ra was significantly increased at both the mRNA and protein levels in whole blood and PBMC samples of PTB patients compared with the healthy controls. The mortality rate increased significantly in SLAMF8 or LILRB4 high expression group compared with SLAMF8 or LILRB4 low expression group. Further, the decrease rate of bacteria in patients with SLAMF8 or LILRB4 high expression was slower than that in patients with SLAMF8 or LILRB4 low expression.ConclusionThis study provides a promising way to identify novel indicators for PTB. Moreover, the LILRB4 expression may play a role in predicting the outcome of treatments on PTB patients.

37 keywords...

hide…